Tenax Therapeutics Inc.

NASDAQ: TENX · Real-Time Price · USD
5.90
-0.05 (-0.84%)
At close: Aug 15, 2025, 3:59 PM
6.09
3.22%
After-hours: Aug 15, 2025, 05:30 PM EDT

Tenax Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-10.85M -10.41M -6.27M -3.96M -3.58M -3.8M -3.23M -1.97M -1.11M -1.41M -2.55M -2.92M -2.86M -2.72M -3.21M -3.8M -1.72M -23.75M
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a 4.71K 969.00 1K 895.00 29.2K 28.51K 28.01K 27.61K 26.83K 26.27K 25.66K 30.22K
Stock-Based Compensation
4.61M 4.14M 1.13M n/a 22.06 118.79 -153 37.01 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
1.25M -607 240.93K n/a 677.89K -476 -648.53K -58.59K n/a n/a 218.7K -30.54K -422.85K 155.09K 74.61K 254.37K 6.72K -778.86K
Other Non-Cash Items
n/a n/a -155.9K 20.9K 31.23K 126.63K 40.02K 45.26K 56.15K 74.76K 82.73K 87.04K 111.63K 85.66K 216.58K 375.79K -152.1K 21.68M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -37.01 -37.01 -50.28 n/a n/a -86.59 -110.03 n/a n/a n/a n/a n/a
Change in Working Capital
-25K -701K 1.77M 852.27K 513.33K -1.49M 2.01M -155.4K 126.27K -393.76K 123.79K -529.84K -709.71K -329.41K 198.69K 375.08K -1.64K -1.18M
Operating Cash Flow
-6.26M -6.97M -3.53M -3.09M -3.03M -5.17M -1.17M -2.08M -922.97K -1.72M -2.31M -3.33M -3.43M -2.94M -2.77M -3.02M -1.85M -3.22M
Capital Expenditures
n/a n/a 3.00 n/a n/a n/a 1.6K 4.00 n/a 1.24K 4K n/a n/a -6.32K -1.7K -1.68K -1.88K n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -2.84K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -118.39K -227.15K
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 513.22K 100K 190.18K
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a 1.24K n/a 1.6K n/a n/a n/a n/a n/a 1.88K n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a n/a n/a n/a n/a 1.6K 1.24K 4K n/a n/a -6.32K -1.7K 511.54K -20.27K -36.96K
Debt Repayment
n/a n/a -97 -278.8K -134.37K -87.73K -174.47K -171.28K -168.16K -110.4K 624.3K -91.88K -136.89K 228.76K n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a -14.19K -282 n/a n/a -7.93K -7.93K n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 340.74K n/a 1.49M 14.19K 282.65K n/a 228.66K 2.06K n/a n/a n/a 8.42M n/a n/a 544.65K
Financial Cash Flow
278K 23.56M 67.25K 92.01M -134.37K 7.92M -174.47K -171.28K -99.91K 14.01M 626.37K -91.88K 7.79M 228.76K n/a 9.19M n/a 544.65K
Net Cash Flow
-5.99M 16.6M -3.46M 88.93M -3.17M 2.76M -1.35M -2.25M -1.02M 12.29M -1.68M -3.42M 4.36M -2.72M -2.77M 6.68M -1.87M -2.71M
Free Cash Flow
-6.26M -6.97M -3.53M -3.09M -3.03M -5.17M -1.17M -2.08M -922.97K -1.72M -2.31M -3.33M -3.43M -2.94M -2.77M -3.02M -1.85M -3.22M